Haemonetics Corporation announced FDA approval for its PerQseal Elite vascular closure system, designed for large-bore arterial procedures using 14-22F sheaths. This sutureless, bioabsorbable patch device offers near-instantaneous hemostasis and leaves no permanent implant, improving patient outcomes and procedural efficiency. The approval follows positive clinical trial results showing zero major complications and a hemostasis time under one minute. Haemonetics plans to present further clinical data at the upcoming TCT Conference, aiming to expand its presence in advanced vascular closure technologies in the U.S.
Haemonetics' FDA approval of the PerQseal Elite vascular closure system provides context for readers interested in medical technology advancements. For readers following the Health sector, here is Pluang's market snapshot as of Oct 20, 2026 03:02 WIB: out of 150 priced Health-sector US stocks, 87 rose and 62 fell. Notable movers include SYRE (Spyre Therapeutics Inc.) at USD 85.02 with a 6.41% increase, TWST (Twist Bioscience Corp) at USD 140.34 with a 5.72% rise and 100% buy order activity, and SLS (SELLAS Life Sciences Group Inc.) at USD 10.50 with a 5.21% gain.
ICICI Bank reported a 20.1% year-over-year rise in standalone profit after tax to INR 148.43 billion for Q2 FY2027, surpassing earnings estimates with ADR earnings of $0.44 per share versus $0.41 expected. Revenue slightly exceeded forecasts at $3.52...
RTX Corporation is set to release its Q3 2026 earnings report on October 20, with Wall Street expecting earnings of $1.78 per share and revenue around $24.1 billion. The company has a strong record of beating earnings estimates for four consecutive q...
The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...
The HCA Healthcare Foundation awarded $25,000 to Waypoint (formerly Virginia Home for Boys and Girls) to expand its network of adults trained to support youth mental wellness across Virginia. This funding supports Waypoint's Therapeutic Resources tea...
Angle Advisors has appointed Chris Gessner as a Managing Director, bringing over 20 years of experience in corporate finance, including lending, private equity, and M&A advisory. Gessner's background spans various transaction types and industries suc...
